• E²-RADIatE - Illustration
    Categories: ,

    The 1500th patient has been enrolled in the E²-RADIatE cohort OLIGOCARE (RP-1822)

    26 Jul 2022

  • Categories: ,

    News from the ESTRO 2021 congress: EORTC-ESTRO RADiation Infrastructure for Europe (E2-RADIatE) OligoCare trial assesses real-world patterns of practice of radical radiotherapy for oligometastatic disease

    28 Aug 2021

  • Categories: ,

    News from the ESTRO 2021 congress: Denis Lacombe, awarded honorary membership of ESTRO, emphasises the importance of radiation oncology in multidisciplinary research

    28 Aug 2021

  • Radiation oncology priorities for clinical trials
    Categories: ,

    Radiation oncology priorities for clinical trials

    13 May 2020

  • E2-RADIate
    Categories: ,

    PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease

    31 Jul 2019

  • Innovation For Value And Acces ESTRO37
    Categories: ,

    EORTC and ESTRO announce a new collaboration to maximise the benefits of radiation oncology

    23 Apr 2018

  • Innovation For Value And Acces ESTRO37
    Categories: ,

    EORTC at ESTRO37 Congress

    19 Apr 2018

  • Brain tumour
    Categories: , ,

    Interim Results of the CATNON Study – the Effects of Temozolomide

    31 Aug 2017